Resources for Startups During COVID-19
(Updated 5/8/2020)
|
|
- COVID-19 Vaccine With Patch Delivery Technology Enters Preclinical Testing at UC Davis.... Read More
- Grants Bolster Campus COVID-19 Research Efforts.... Read More
- Final Round of Competitive Grants Awarded to Fight COVID-19.... Read More
- ‘Sick Posts’ on Social Media Help Early Tracking of COVID-19.... Read More
- UC Davis Researchers Launch New COVID-19 Tracking Application.... Read More
- Remdesivir Improved Majority of Patients Hospitalized With Severe COVID-19.... Read More
- How Important Is Speech in Transmitting Coronavirus?.... Read More
- Genome Variation Gives Insight Into Coronavirus Spread.... Read More
- UC Davis Health Joins State on Testing.... Read More
|
|
UC Davis Venture Catalyst Knowledge Exchange Webinar
U.S. Immigration Paths and Strategies for Startups and Entrepreneurs
|
|
Featuring:
- Brian Graham, Partner, K&L Gates
Navigating immigration paths and strategies can be a challenge for startups. This talk, led by Brian Graham, Partner at the law firm K&L Gates, will explore the U.S. immigration options available to entrepreneurs and company founders. The discussion will compare and contrast the F-1, J-1, H-1B, E-1/E-2, O-1, L-1 and TN visa classifications and will cover proper and improper uses of the B-1 business visitor classification and ESTA. The talk will also discuss nonimmigrant versus immigrant classifications and how they apply to entrepreneurs.
When:
Tuesday, May 19, 2020, 10:30 – 11:45 am
|
|
UC Davis Releases 6 New Varieties of Organic Beans
|
|
Plant breeders at UC Davis are releasing six new varieties of organic beans. Field trials found that the new varieties produced high yields, and were resistant to bean common mosaic virus, a disease that prevents bean plants from maturing promptly and uniformly. Breeders worked with organic growers to choose heirloom and traditional bean varieties that had excellent flavor and aesthetics but are somewhat uncommon because they don’t always perform well in the field. Breeders cross-pollinated traditional and heirloom varieties and carefully selected the best characteristics of both groups....
Read More
|
|
UC Davis Health Researchers are Awarded Additional $4 Million to Develop New Therapies for Pancreatic Cancer
|
|
The Pancreatic Cancer Collective has awarded additional funding of $4 million to UC Davis scientist Dr. Julie Sutcliffe and surgical oncologist Dr. Richard Bold as part of a “New Therapies Challenge Grant.” This is the group’s second award for Sutcliffe and Bold, who received an initial grant of $1 million in fall 2018 for research efforts to improve survival for people with the disease. The approach, known as peptide receptor radionuclide therapy (PRRT), will allow the selective delivery of radiation therapy internally to a patient so the treatment will kill pancreatic cancer cells at any site within a patient’s body....
Read More
|
|
New Study Suggests Ways to Alleviate Social Withdrawal Symptoms in Mental Illnesses
|
|
Researchers at UC Davis studied the role of oxytocin, a neurotransmitter produced in the hypothalamus, which is known to play an important role in social behavior across species. By analyzing the behavior of mice receiving different treatments, they gained insight into whether oxytocin may be a good target for future pharmacological therapies that could alleviate social withdrawal in mental illness. Researchers found that after mice experienced negative social interactions, they had less expression of the oxytocin receptor gene....
Read More
|
|
Computer Model Predicts How Drugs Affect Heart Rhythm
|
|
UC Davis Health researchers have developed a computer model to screen drugs for unintended cardiac side effects, especially arrhythmia risk. Published in Circulation Research, the study was led by Colleen E. Clancy, professor of physiology and membrane biology, and Igor Vorobyov, assistant professor of physiology and membrane biology....
Read More
|
|
Award Supports Cutting-Edge Biomedical Research to Benefit Children With Cerebral Palsy
|
|
UC Davis Assistant Professor Lucas Smith was selected by The Hartwell Foundation to receive the prestigious 2019 Hartwell Individual Biomedical Research Award. The award will support Smith’s research on finding promising therapies that can improve mobility and quality of life for children with Cerebral Palsy....
Read More
|
|
Genetic Variation Not an Obstacle to Gene Drive Strategy to Control Mosquitoes
|
|
New research from entomologists at UC Davis clears a potential obstacle to using CRISPR-Cas9 “gene drive” technology to control mosquito-borne diseases such as malaria, dengue fever, yellow fever and Zika. The idea is to create genetically engineered mosquitoes (GEM) that either fail to reproduce, reducing the mosquito population, or that resist carrying viruses and parasites that cause disease. These mosquitoes would be created in a lab and released to interbreed with wild mosquitoes. Using the Cas 9 enzyme, researchers can ensure that the new, modified genes would be inherited by all of the mosquito’s offspring when they mate with wild mosquitoes....
Read More
|
|
Arcadia Biosciences Significantly Expands Intellectual Property Portfolio with Four U.S. Patents
Arcadia Biosciences announced that the U.S. Patent and Trademark Office has awarded the company two patents for extending the shelf life of whole wheat by minimizing hydrolytic and oxidative rancidity. The company also received notices of allowance for two additional patents extending earlier claims surrounding the extended shelf life of wheat and reduced gluten grains.
The new patents bring the total number of patents in Arcadia’s GoodWheat™ portfolio of non-genetically modified (non-GM) wheat varieties to 22.....
Read More
|
New Study: Infant Gut Health Must Focus on Microbiome Function, Not Diversity
A new peer-reviewed perspective by Evolve BioSystems was published with an objective to assist neonatologists and other pediatric health care professionals in assessing the state of the infant gut microbiome, which plays a significant role in immune development and metabolism in infants. The study validates the critical functional role
B. infantis
plays in breaking down human oligosaccharides from breastmilk to release energy for the infant, regulate immune development, and prevent the growth of pathogenic gut bacteria.....
Read More
|
Sacramento Startup Profile: JAPA Co-Founder Mathew Magno
StartupSac conducted an interview with Mathew Magno, co-founder of JAPA, a Sacramento-based technology startup. JAPA delivers real-time parking availability to drivers and enhanced parking analytics to parking lot owners/management....
Read More
|
Galy Grows Greener Cotton In A Lab, 10 Times Faster Than The Farm Variety
(Forbes)
Galy is an early-stage startup transforming the cotton industry by engineering cotton in labs that can grow about 10 times faster than the farming alternative without being dependent on soil and weather. The company won the annual Global Change Award from the Sweden-based H&M Foundation with a prize of approximately $330,000....
Read More
|
Startup Career Opportunities
|
Career Opportunities at AnimalBiome
AnimalBiome is currently hiring for an animal care specialist and a laboratory technician....
Learn more
|
Career Opportunities at Arcadia Biosciences
Arcadia Biosciences is hiring for a
Technical Seed Sales & Agronomy Advisor
..
..
Learn more
|
Career Opportunities at Evolve Biosystems
Evolve Biosystems is currently hiring for two research associates and a management position....
Learn More
|
Career Opportunities at Novoheart
Novoheart is currently hiring for an engineer and
three scientist positions
....
Learn more
|
Career Opportunities at Sage Therapeutics
Sage Therapeutics is hiring for a wide range of positions from Vice President of Pharmacovigilance & Drug Safety to director level positions....
Learn more
|
News from the DRIVE Network
|
HM.CLAUSE is Hiring an Intellectual Property and Innovation Center Leader
HM.CLAUSE is seeking a dynamic and innovative leader to to support intellectual property protection, champion innovation, and work in collaboration with Venture Catalyst to manage UC Davis-HM.CLAUSE Life Science Innovation Center....
Read More
|
Sacramento Media Tech Company Fantag Acquired
(Sacramento Business Journal
)
Fatang, a Sacramento-based company that developed a cloud-based platform to allow sports fans to record and share game highlights with their smartphones, was acquired by the Omaha-based ScoreVision LLC. Fantag moved to Sacramento in 2017 from Palo Alto and has since raised over $1 million in venture capital. Fantag will become ScoreVision's West Coast office....
Read More
|
Gold Standard Diagnostics COVID-19 Antibody Tests Now Available
The Gold Standard Diagnostics Group announced the immediate availability of three different serological assays for detection of antibodies against the novel coronavirus SARS-CoV-2. The company followed the FDA’s Emergency Use Notification process as provided in the FDA’s Policy for Diagnostic Tests for Coronavirus Disease-2019 during the Public Health Emergency....
Read More
|
Rancho Cordova Scientists Hope to Market Coronavirus Treatment to Hospitals in 2 Months
(Sacramento Bee)
By using its own rapid IgM/IgG antibody detection technology, along with its own proprietary multi-component automated cell separating system, ThermoGenesis, a Rancho Cordova-based company is hoping to market a COVID-19 treatment to hospitals. The treatment will use the antibodies from a recovered individual to treat patients with COVID-19....
Read More
|
Marrone Bio Innovations Secures $1.7 Million Loan Under Paycheck Protection Program Provision of CARES Act
Marrone Bio Innovations, an international leader in sustainable bioprotection and plant health solutions, secured a $1.7 million loan under the Paycheck Protection Program (PPP) contained within the Coronavirus Aid, Relief and Economic Security (CARES) Act.....
Read More
|
|
Venture Well Design by Biomedical Undergraduate Teams Challenge
|
Research Investments in Cannabis and Hemp (RICH)
Application Deadline: June 17, 2020....
Learn More
|
CITRIS Core Seed Funding
Application Deadline: September 10, 2020....
Learn More
|
IndieBio Accelerator
Application Deadline: Currently accepting....
Learn More
|
Rapid Acceleration of Diagnostics (RADx)
|
Educational Opportunities
|
Big Bang! Business Competition Final Presentations and Awards Ceremony (Virtual)
|
UC Davis Institute for Innovation & Entrepreneurship Undergraduate
Entrepreneurship Academy (Virtual)
|
How to get investors, Partners, and Buyers to Notice You (Virtual)
|
UC Davis Institute for Innovation & Entrepreneurship National Veterinary Entrepreneurship Academy
|
UC Davis Institute for Innovation & Entrepreneurship UC Entrepreneurship Academy
|
Please check event websites for the latest updates regarding any cancellations or postponements due to COVID-19
|
Small Business Development Center Workshops
|
Silicon Valley USPTO Workshops
|
Bay Area NSF Innovation Corps Immersive Short Courses
|
Please check event websites for the latest updates regarding any cancellations or postponements due to COVID-19
|
JLABS Virtual Educational Events
|
American Association for Mass Spectrometry Annual Conference (Virtual Event)
|
BIO Digital (Virtual Event)
|
Xcelerating Life Sciences (Virtual Event)
|
Silicon Valley AgTech Conference (San Jose, CA)
|
|
Startup Ecosystem Faces Capital Crunch over Coming Months – What We Expect & Why It Matters
(National Venture Capital Association)
Over the next several quarters, the National Venture Capital Association (NVCA), expects to see more layoffs, limitations and decrease in VC investing, and stalled exit activity....
Read More
|
|
The Face Of Angel Investing Is Changing. Here’s What You Need To Know
(Forbes)
Angel Investors in general are becoming increasingly hesitant in investing during the coronavirus outbreak. However, some more seasoned investors are still continuing to support the investments, albeit into more niche markets and technologies.
.
...
Read More
|
|
Life Science a VC Bright Spot in Q1, But Startups May Soon Struggle
(Xconomy)
During first quarter of 2020, venture investment in the life sciences represented roughly 20 percent of all activity with a total of $7.1 billion covering 366 deals. However, moving into the second quarter and beyond the COVID-19 situation will likely begin to show notable impacts on startups and venture capital investors......
Read More
|
|
|
About Venture Catalyst
UC Davis Venture Catalyst
supports the development of new ventures fueled by university research and technology. Venture Catalyst offers several innovative programs that bridge the gap between early-stage research and commercialization and provide entrepreneurs the resources, support, and connections needed to successfully form and grow technology-based startups. With a focus on accelerating technology-led economic development in the Davis-Sacramento region, Venture Catalyst also works closely with partners in the regional innovation and economic development ecosystems.
Contact Venture Catalyst
For more information or for editorial comments, please
email us
.
|
|
|
|
|
|
|
